NASDAQ
17.74USD
+0.39 (+2.25%)
We have scored 7 news catalysts on Carlsmed, Inc. (CARL) over the past 12 months. The biggest single-day move next to one of them came Apr 1, 2026, when CARL closed +6.4%: “Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference”. Coverage across the window leans positive (average ticker sentiment +0.47). Most of the impact sits in short squeeze potential and price momentum.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
486.1M
P/E
—
EPS
—
Beta
1.97
52W range
8.5-19.153
Day range
17.20–18.61
Open
17.30
Prev close
17.35
Volume
292.4K
Avg volume
124.1K
Dividend
0.00
IPO
2025-07-23
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Carlsmed, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for CARL: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.